biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30

$1.06+0.03 (+3.40%)

Close on Nov 13, 2026Market cap $38.26MP/E –Yield –

biote statistics

94 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 10, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $38.26M; $272.32M
Enterprise Value: $157.24M; $146.23M
PS Ratio: 0.21; 3.66
P/FCF Ratio: 5.17; 17.86
P/OCF Ratio: 2.74; 12.99

Enterprise valuationIndustry

EV / Sales: 0.88; 2.57
EV / EBITDA: 12.19; 16.50
EV / EBIT: 17.52; 19.31
EV / FCF: 21.23; 22.27

Share statisticsIndustry

Shares Outstanding: 36M; 58M
Shares Change (YoY): -10.3%; 10.8%
Float: 28M; 49M
Shares Held by Insiders: 23.3%; 11.7%
Shares Held by Institutions: 36.6%; 56.4%

Short sellingIndustry

Short Interest: 841,390; –
Short Interest Change: -28.8%; -0.80%
Short % of Float: 3.05%; 9.01%
Short % of Shares Outstanding: 2.34%; 6.30%
Days to Cover: 10.21; 5.15

Stock price statisticsIndustry

52-Week High: $2.90; –
52-Week Low: $0.99; –
20-Day Moving Average: $1.10; –
50-Day Moving Average: $1.19; –
200-Day Moving Average: $1.77; –
Average True Range (14): $0.10; –
Price Change (1 Week): 0.47%; -1.15%
Price Change (1 Month): -4.05%; -4.87%
Price Change (3 Months): -22.3%; -21.0%
Price Change (6 Months): -45.9%; -20.6%
Price Change (YTD): -59.0%; -23.6%
Price Change (1 Year): -59.7%; -22.4%
Price Change (3 Years): -78.7%; -29.5%
Price Change (5 Years): -89.1%; -77.9%
Average Volume (10 Days): 111,621; –
Average Volume (20 Days): 99,445; –
Average Volume (90 Days): 193,891; –
Relative Volume: 0.34; 0.70
Relative Strength Index (14): 44.5; 43.4
Volatility (1 Year): 76.2%; 80.1%
Beta (5 Years): 0.51; 1.07

MarginsIndustry

Gross Margin: 67.5%; 53.1%
Operating Margin: 5.02%; -38.7%
Pretax Margin: 1.77%; -11.6%
Profit Margin: -1.08%; -31.6%
EBITDA Margin: 7.21%; -27.7%
FCF Margin: 4.14%; -9.56%

Returns on capitalIndustry

Return on Assets (ROA): -1.81%; -40.6%
Return on Invested Capital (ROIC): 18.5%; -32.9%
Return on Capital Employed (ROCE): 12.6%; -37.9%

Financial positionIndustry

Current Ratio: 1.37; 3.30
Quick Ratio: 0.53; 2.39
Debt / EBITDA: 9.31; 3.15
Debt / FCF: 16.21; 4.65
Net Debt / EBITDA: 8.62; 1.97

GrowthIndustry

Revenue Growth (YoY): -8.55%; 6.82%
Net Income Growth (YoY): -106.7%; -14.4%
EPS Growth (YoY): -113.9%; -12.3%
FCF Growth (YoY): -78.5%; 6.85%
Revenue Growth (3Y CAGR): 5.23%; 2.25%

EfficiencyIndustry

Asset Turnover: 1.68; 0.40
Inventory Turnover: 3.40; 2.73
Revenue Per Employee: $802.28K; $429.29K
Profits Per Employee: -$8.63K; -$689.41K
Employee Count: 223; 74
WACC: 5.35%; 10.2%

Income statement (TTM)Industry

Revenue: $178.91M; $66.37M
Gross Profit: $120.78M; $120.78M
Operating Income: $8.97M; -$21.37M
Pretax Income: $3.17M; -$12.95M
Net Income: -$1.93M; -$22.35M
EBITDA: $12.90M; -$17.21M
EPS (Diluted): -$0.11; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $8.85M; $68.68M
Total Debt: $120.07M; $116.91M
Net Cash (Debt): -$111.22M; $17.76M
Net Cash Per Share: -$3.10; $0.80
Equity (Book Value): -$65.35M; $53.89M
Book Value Per Share: -$1.82; $1.50
Tangible Book Value: -$74.52M; $27.13M
Working Capital: $11.26M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: $13.98M; -$12.38M
Capital Expenditures: -$6.57M; -$1.00M
Free Cash Flow: $7.41M; -$18.21M
FCF Per Share: $0.21; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -5.03%; -21.8%
FCF Yield: 19.4%; -9.44%
Buyback Yield: 18.9%; -0.76%
Shareholder Yield: 18.9%; 0.00%
FCF Payout Ratio: 15.8%; 43.7%

Taxes and interestIndustry

Income Tax: $4.74M; $73.00K
Effective Tax Rate: 149.3%; 20.9%

Scores and fair valueIndustry

Altman Z-Score: 1.65; 0.23
Piotroski F-Score: 6; 4
Beneish M-Score: -2.70; -2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	BTMD	S&P 500	Difference	BTMD per year	S&P 500 per year
1 month	+2.4%	-3.0%	+5.4 pts
3 months	-28.5%	-2.8%	−25.7 pts
Year to date	-59.0%	+11.5%	−70.5 pts
1 year	-59.0%	+13.5%	−72.5 pts
3 years	-78.0%	+77.7%	−155.7 pts	-39.6%	+21.1%
5 years	-89.1%	+72.6%	−161.7 pts	-35.8%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M BTMD shares were sold short on Oct 30, 2026, down 28.8% from the previous report, or 3.05% of the shares available to trade. At recent volumes it would take 10.2 days to buy them back. Over the last 20 sessions, 45.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	841,390	-28.8%	82,442	10.2
Oct 15, 2026	1,181,025	+9.0%	156,846	7.5
Sep 30, 2026	1,083,323	-15.4%	102,010	10.6
Sep 15, 2026	1,280,901	-8.2%	247,392	5.2
Aug 31, 2026	1,395,764	+111.8%	408,776	3.4
Aug 14, 2026	658,978	+22.3%	219,598	3.0
Jul 31, 2026	538,647	-6.9%	206,087	2.6
Jul 15, 2026	578,682	+4.5%	205,004	2.8
Jun 30, 2026	553,643	-57.0%	624,792	1.0
Jun 15, 2026	1,287,328	-8.9%	208,682	6.2
May 29, 2026	1,412,998	-13.0%	228,013	6.2
May 15, 2026	1,623,663	+9.5%	228,150	7.1